“NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROSTATE CANCER”. 2019. Voprosy Onkologii 65 (5): 726-35. https://doi.org/10.37469/0507-3758-2019-65-5-726-735.